Azzad Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$897K Sell
4,602
-4
-0.1% -$829 0.08% 250
2026
Q1
$1.03M Buy
4,606
+143
+3% +$35.6K 0.1% 226
2025
Q4
$1.08M Buy
4,463
+3,261
+271% +$834K 0.11% 226
2025
Q3
$329K Buy
+1,202
New +$328K 0.03% 304
2021
Q3
Sell
-1,035
Closed -$255K 338
2021
Q2
$255K Hold
1,035
0.04% 309
2021
Q1
$201K Hold
1,035
0.03% 306
2020
Q4
$220K Buy
+1,035
New +$206K 0.04% 281
2020
Q1
Sell
-2,074
Closed -$360K 337
2019
Q4
$360K Hold
2,074
0.04% 326
2019
Q3
$339K Buy
+2,074
New +$272K 0.04% 325

Other funds holding RMD

Azzad Asset Management's RMD Position: Q2 2026 in Review

Azzad Asset Management reduced its ResMed (RMD) stake by 0.09% in Q2 2026, selling an estimated $829 and leaving 4,602 shares worth $897K. The position accounts for 0.08% of the portfolio, ranked #250.

Azzad Asset Management first reported a position in RMD in Q3 2019 and has held it in 9 quarters since. The position peaked at $1.08M in Q4 2025. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Azzad Asset Management held 4,602 shares of ResMed worth $897K as of Q2 2026.
  • Azzad Asset Management sold 4 ResMed shares in Q2 2026, an estimated $829.
  • ResMed made up 0.08% of Azzad Asset Management's portfolio in Q2 2026, its #250 holding.
  • Azzad Asset Management first reported a position in ResMed in Q3 2019 and has held it in 9 quarters since.
  • Azzad Asset Management's ResMed position peaked at $1.08M in Q4 2025.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.